Abstract
FOR some years we have been investigating the biological properties of substituted phenylalkanoic and phenoxy-alkanoic acids and related compounds. We wish to describe briefly the properties of one of these, ‘Ibufenac’, which Chalmers and Duthie have recently shown to be effective in the treatment of rheumatoid arthritis1.
Similar content being viewed by others
References
Chalmers, T. M., and Duthie, J. J. R., Ann. Rheum. Dis. (in the press).
Adams, S. S., and Cobb, R., Nature, 181, 773 (1958).
Randall, L. O., and Selitto, J. J., Arch. Int. Pharmacodyn., 111, 409 (1957).
Silber, R. H., Ann. N.Y. Acad. Sci., 82, 821 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ADAMS, S., CLIFFE, E., LESSEL, B. et al. Some Biological Properties of ‘Ibufenac’, a New Anti-rheumatic Drug. Nature 200, 271–272 (1963). https://doi.org/10.1038/200271b0
Issue Date:
DOI: https://doi.org/10.1038/200271b0
- Springer Nature Limited
This article is cited by
-
Diaryloxazole and Diarylthiazolealkanoic Acids: Two Novel Series of Non-steroidal Anti-inflammatory Agents
Nature (1968)
-
Inhibition of Conjugation by Anti-inflammatory Drugs
Nature (1965)
-
Uncoupling of Oxidative Phosphorylation by some Arylacetic Acids (Anti-inflammatory or Hypocholesterolemic Drugs)
Nature (1964)